Champions Oncology (CSBR) Cash from Operations Growth (5y) (2015 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -33.73% |
| Apr 30, 2026 | -0.18% |
| Jan 31, 2026 | -64.15% |
| Oct 31, 2025 | -31.78% |
| Jul 31, 2025 | 23.21% |
| Apr 30, 2025 | 21.96% |
| Jan 31, 2025 | 11.92% |
| Oct 31, 2024 | -22.74% |
| Jul 31, 2024 | 25.51% |
| Apr 30, 2024 | -55.89% |
| Jan 31, 2024 | -22.51% |
| Oct 31, 2023 | 55.88% |
| Jul 31, 2023 | -69.23% |
| Apr 30, 2023 | -139.55% |
| Jan 31, 2023 | 28.73% |
| Oct 31, 2022 | 65.08% |
| Jul 31, 2022 | 36.89% |
| Apr 30, 2022 | 14.87% |
| Jan 31, 2022 | 52.41% |
| Oct 31, 2021 | 60.31% |